Sodium Bicarbonate Injection bulk supplier for pharma manufacturers

Sodium Bicarbonate Injection 8.4% (1 mEq/mL) Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Injection

Available Strengths: 8.4% (1 mEq/mL)

Reference Brands: Sodium Bicarbonate Injection

Sodium Bicarbonate IV (4.2% & 8.4%) is widely used in emergency care for acidosis and cardiac arrest. Leading brands include Pfizer, Fresenius, and B. Braun. Pharma B2B platforms ensure dependable bulk supply of Sodium Bicarbonate injection for hospitals, ICUs, and life-saving critical care environments in US and EU markets.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Product Description:

Sodium Bicarbonate is an essential alkalinizing agent used in emergency and critical care to treat metabolic acidosis, cardiac arrest, hyperkalemia, and certain drug overdoses. It is most commonly administered as an IV solution in 4.2% or 8.4% concentrations. Key brands include Pfizer, Fresenius Kabi, Hospira, and B. Braun, with available formats including vials, ampoules, and prefilled syringes. Sodium Bicarbonate IV is a life-saving hospital medicine, especially in ICUs and emergency departments. Pharma B2B platforms offer reliable, large-scale procurement of Sodium Bicarbonate solutions, supporting continuous supply for healthcare institutions across the US, EU, and other regulated global markets.

Sodium Bicarbonate Injection — third party manufacturing & bulk supply

Sodium Bicarbonate Injection 8.4% (1 mEq/mL) is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Sodium Bicarbonate Injection is supplied as Intravenous (IV) Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Sodium Bicarbonate Injection listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Sodium Bicarbonate Injection →

Back to Listing

Frequently Asked Questions

Sodium Bicarbonate Injection is listed as Intravenous (IV) Injection in 8.4% (1 mEq/mL). Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Sodium Bicarbonate Injection is referenced against Sodium Bicarbonate Injection. Reference brands are shown for identification only and remain the property of their respective trademark owners.